3-Phenoxybenzaldehyde
C1s-IN-1
N-((Allyloxy)carbonyl)-N-methyl-L-alanine
Crovalimab
Pozelimab
Pexelizumab
Olendalizumab
Gefurulimab
Gavilimomab
Avdoralimab
Vilobelimab
Tesidolumab
Ravulizumab
Vesencumab
Lampalizumab
Sutimlimab
Riliprubart
Empasiprubart
C5a Receptor agonist, W5Cha
C5a Anaphylatoxin (human)